GTBPVSVTGN• 3 Months (Normalized)
GTBP vs VTGN (GT Biopharma Inc. vs Vistagen Therapeutics Inc.)
Showing Closing Date Range from Jun 30 to Sep 28, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
GTBP Performance $7.1
+1348.98%
GT Biopharma Inc.
Normalized Baseline0.00%
VTGN Performance $0.37
+60.87%
Vistagen Therapeutics Inc.
Normalized Baseline0.00%
Alpha Spread Margin GTBP LEADS
+1288.11 pts
GTBP outperforming by 1288.11 percentage points
GTBPVTGN
Spread Trajectory3 Months (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
GTBP VTGN
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(60 dates)
| Date | GTBP Price | GTBP Gain (%) | VTGN Price | VTGN Gain (%) | Spread |
|---|---|---|---|---|---|
| Sep 23, 2026 | $7.10 | +1348.98% | $0.37 | +60.87% | +1288.11% |
| Sep 22, 2026 | $- | $0.25 | +8.70% | - | |
| Sep 21, 2026 | $7.18 | +1365.31% | $0.23 | +0.00% | +1365.31% |
| Sep 18, 2026 | $7.16 | +1361.22% | $0.24 | +4.35% | +1356.87% |
| Sep 17, 2026 | $7.49 | +1428.57% | $0.23 | +0.00% | +1428.57% |
| Sep 16, 2026 | $7.81 | +1493.88% | $0.23 | +0.00% | +1493.88% |
| Sep 15, 2026 | $9.00 | +1736.73% | $0.24 | +4.35% | +1732.38% |
| Sep 14, 2026 | $11.63 | +2273.47% | $0.24 | +5.74% | +2267.73% |
| Sep 11, 2026 | $8.61 | +1657.14% | $0.24 | +4.35% | +1652.79% |
| Sep 10, 2026 | $6.18 | +1161.22% | $0.24 | +4.35% | +1156.87% |
| Sep 09, 2026 | $5.98 | +1120.41% | $0.24 | +4.35% | +1116.06% |
| Sep 08, 2026 | $- | $0.24 | +4.35% | - | |
| Sep 04, 2026 | $0.24 | -50.82% | $0.24 | +4.35% | -55.17% |
| Sep 03, 2026 | $0.25 | -48.57% | $0.25 | +8.70% | -57.27% |
| Sep 02, 2026 | $0.28 | -42.24% | $0.25 | +8.70% | -50.94% |
Page 1 of 4